首页> 美国卫生研究院文献>Journal of Clinical Medicine >Self-Collection of Saliva Specimens as a Suitable Alternative to Nasopharyngeal Swabs for the Diagnosis of SARS-CoV-2 by RT-qPCR
【2h】

Self-Collection of Saliva Specimens as a Suitable Alternative to Nasopharyngeal Swabs for the Diagnosis of SARS-CoV-2 by RT-qPCR

机译:通过RT-QPCR诊断SARS-COV-2的鼻咽拭子的唾液标本的自集替代品

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

A nasopharyngeal swab is a sample used for the diagnosis of SARS-CoV-2 infection. Saliva is a sample easier to obtain and the risk of contagion for the professional is lower. This study aimed to evaluate the utility of saliva for the diagnosis of SARS-CoV-2 infection. This prospective study involved 674 patients with suspected SARS-CoV-2 infection. Paired nasopharyngeal and saliva samples were processed by RT-qPCR. Sensitivity, specificity, and kappa coefficient were used to evaluate the results from both samples. We considered the influence of age, symptoms, chronic conditions, and sample processing with lysis buffer. Of the 674 patients, 636 (94.4%) had valid results from both samples. The virus detection in saliva compared to a nasopharyngeal sample (gold standard) was 51.9% (95% CI: 46.3%–57.4%) and increased to 91.6% (95% CI: 86.7%–96.5%) when the cycle threshold (Ct) was ≤ 30. The specificity of the saliva sample was 99.1% (95% CI: 97.0%–99.8%). The concordance between samples was 75% (κ = 0.50; 95% CI: 0.45–0.56). The Ct values were significantly higher in saliva. In conclusion, saliva sample utility is limited for clinical diagnosis, but could be a useful alternative for the detection of SARS-CoV-2 in massive screening studies, when the availability of trained professionals for sampling or personal protection equipment is limited.
机译:鼻咽拭子是用于诊断SARS-COV-2感染的样品。 Saliva是一个更容易获得的样本,专业人士传染的风险较低。本研究旨在评估唾液诊断SARS-COV-2感染的效用。这项前瞻性研究涉及674例怀疑SARS-COV-2感染患者。通过RT-QPCR处理成对的鼻咽和唾液样品。使用敏感性,特异性和κ系数来评估两个样品的结果。我们考虑了年龄,症状,慢性病条件和用裂解缓冲液的样品加工的影响。在674名患者中,636(94.4%)有两种样品的有效结果。唾液中的病毒检测与鼻咽样品(黄金标准)相比为51.9%(95%CI:46.3%-57.4%),当循环阈值(CT)时增加至91.6%(95%CI:86.7%-96.5%)(CT )≤30.唾液样品的特异性为99.1%(95%CI:97.0%-99.8%)。样品之间的一致性为75%(κ= 0.50; 95%CI:0.45-0.56)。唾液中CT值显着较高。总之,唾液样品效用受到临床诊断的限制,但是当训练有素的采样或个人保护设备的可用性受到限制时,可以是在大规模筛查研究中检测SARS-COV-2的有用替代方案。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号